Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer

Clinical Cancer Research

Volumn 11, Issue 20, 2005, Pages 7376-7383

  Chan, Michael W Y ^a   Wei, Susan H ^a   Wen, Ping ^b   Wang, Zailong ^c   Matei, Daniela E ^d   Liu, Joseph C ^a   Liyanarachchi, Sandya ^a   Brown, Robert ^e   Nephew, Kenneth P ^d   Yan, Pearlly S ^a   Huang, Tim H M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Immunology and Medical Genetics   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA ACTIN; BISULFITE; DNA 18S; DNA 28S; GENOMIC DNA; RIBOSOME DNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; AZACITIDINE; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA, RIBOSOMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; RNA, RIBOSOMAL, 18S; RNA, RIBOSOMAL, 28S; SURVIVAL ANALYSIS;

EID: 27144499187     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-1100     Document Type: Article

References (31)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
3. Nephew KP, Huang TH. Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 2003;190:125-33.
4. Leu YW, Yan PS, Fan M, et al. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res 2004;64:8184-92.
5. Yan PS, Shi H, Rahmatpanah F, et al. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res 2003;63:6178-86.
6. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54.
7. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
8. Strathdee G, Appleton K, Illand M, et al. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol 2001;158:1121-7.
9. Yoon JH, Dammann R, Pfeifer GP. Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas. Int J Cancer 2001;94:212-7.
10. Widschwendter M, Jiang G, Woods C, et al. DNA hypomethylation and ovarian cancer biology. Cancer Res 2004;64:4472-80.
11. Nishiyama R, Qi L, Tsumagari K, et al. A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in others. Cancer Biol Ther 2005;4.
12. Nagai H, Kim YS, Yasuda T, et al. A novel sperm-specific hypomethylation sequence is a demethylation hotspot in human hepatocellular carcinomas. Gene 1999;237:15-20.
13. Yan PS, Rodriguez FJ, Laux DE, Perry MR, Standiford SB, Huang TH. Hypermethylation of ribosomal DNA in human breast carcinoma. Br J Cancer 2000;82:514-7.
14. Powell MA, Mutch DG, Rader JS, Herzog TJ, Huang TH, Goodfellow PJ. Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker. Cancer 2002;94:2941-52.
15. Worton RG, Sutherland J, Sylvester JE, et al. Human ribosomal RNA genes: orientation of the tandem array and conservation of the 5′ end. Science 1988;239:64-8.
16. Dante R, Percy ME, Baldini A, et al. Methylation of the 5′ flanking sequences of the ribosomal DNA in human cell lines and in a human-hamster hybrid cell line. J Cell Biochem 1992;50:357-62.
17. Gonzalez IL, Wu S, Li WM, Kuo BA, Sylvester JE. Human ribosomal RNA intergenic spacer sequence. Nucleic Acids Res 1992;20:5846.
18. Shi SR, Cote RJ, Wu L, et al. DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem 2002;50:1005-11.
19. Chan MW, Chu ES, To KF, Leung WK. Quantitative detection of methylated SOCS-1, a tumor suppressor gene, by a modified protocol of quantitative real time methylation-specific PCR using SYBR green and its use in early gastric cancer detection. Biotechnol Lett 2004;26:1289-93.
20. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6.
21. Toyota M, Ahuja N, Suzuki H, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999;59:5438-42.
22. Costello JF, Fruhwald MC, Smiraglia DJ, et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24:132-8.
23. Parrella P, Poeta ML, Gallo AP, et al. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res 2004;10:5349-54.
24. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-93.
25. Widschwendter M, Jones PA. The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Commentary re: Kwong J, et al. Clin Cancer Res 2002;8:131-7
26. and Zou H-Z, et al. Clin Cancer Res 2002;8:188-91.
27. Clin Cancer Res 2002;8:17-21.
28. Esteller M, Garcia-Foncillas J, Andion E, et al, Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000;343:1350-4.
29. Cheng RY, Hockman T, Crawford E, Anderson LM, Shiao YH. Epigenetic and gene expression changes related to transgenerational carcinogenesis. Mol Carcinog 2004;40:1-11.
30. Santoro R, Grummt I. Molecular mechanisms mediating methylation-dependent silencing of ribosomal gene transcription. Mol Cell 2001;8:719-25.
31. Santoro R, Li J, Grummt I. The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription. Nat Genet 2002;32:393-6.